title: Endothelin-induced vascular and bronchial effects in pig airways: role in acute allergic responses.
abstract: The effects of endothelin (ET) agonists on airway mechanics and bronchial blood flow were studied as well as the effects of mixed ET-receptor antagonist bosentan on allergen-induced airway reactions in the pig. ET agonists [ET-1, ET-3, and the ET(B) receptor-selective agonist Sarafotoxin 6c (Sf6c)] were given as intravenous injections (0.4-200 pmol/kg) to eight anesthetized pigs. Bosentan (10 mg/kg iv) was then administered, and the injections were repeated. Only Sf6c caused a significant increase in airway resistance, and this response was blocked by bosentan. Sf6c and ET-1 (200 and 400 pmol/kg, respectively) were also given as aerosols to five pigs. Sf6c, but not ET-1, caused bronchoconstriction via this route. All agonists (intravenous) caused increases in bronchial vascular conductance, an effect that was blocked by an NO-synthase inhibitor (N(G)-nitro-L-arginine) but unaffected by a cyxlooxygenase inhibitor (diclofenac). Fourteen pigs were sensitized with ascaris suum antigen. Under anesthesia, eight pigs were pretreated with bosentan, and six pigs were controls. They were all challenged with allergen aerosol resulting in acute bronchoconstriction and elevation of ET-1 in bronchoalveolar lavage fluid. Bosentan did not affect the maximal acute airway obstruction but markedly increased baseline bronchial vascular conductance, suggesting a basal vascular tone regulated by ETs. In conclusion, ETs induce bronchoconstriction primarily via the ET(B) receptor in the pig. However, ETs are probably not involved in the allergen-induced acute bronchoconstriction in this model.
authors.affiliation: Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
authors.forename: H
authors.initials: H
authors.lastname: Sylvin
authors.forename: E
authors.initials: E
authors.lastname: Weitzberg
authors.forename: K
authors.initials: K
authors.lastname: Alving
mesh_terms: D000208:Acute Disease; D000403:Airway Resistance / Q000187:drug effects; D000818:Animals; D017165:Ascaris suum / Q000276:immunology; D000077300:Bosentan; D001980:Bronchi / Q000187:drug effects / Q000502:physiology* / Q000503:physiopathology; D016084:Bronchoconstriction; D016085:Bronchoconstrictor Agents / Q000494:pharmacology; D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1 / Q000494:pharmacology; D016232:Endothelins / Q000378:metabolism*; D006967:Hypersensitivity / Q000503:physiopathology; D011652:Pulmonary Circulation / Q000187:drug effects / Q000502:physiology*; D013449:Sulfonamides / Q000494:pharmacology; D013552:Swine; D014757:Viper Venoms / Q000494:pharmacology
chemical_list: D016085:Bronchoconstrictor Agents; D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1; D016232:Endothelins; D013449:Sulfonamides; D014757:Viper Venoms; C057354:sarafotoxins s6; D000077300:Bosentan